Provided by Tiger Trade Technology Pte. Ltd.

Legend Biotech

17.00
-0.6700-3.79%
Post-market: 17.100.1000+0.59%19:56 EDT
Volume:3.53M
Turnover:60.47M
Market Cap:3.31B
PE:-33.95
High:18.04
Open:17.86
Low:16.86
Close:17.67
52wk High:37.50
52wk Low:16.24
Shares:194.49M
Float Shares:91.34M
Volume Ratio:1.24
T/O Rate:3.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5008
EPS(LYR):-1.6200
ROE:-8.08%
ROA:-1.92%
PB:2.69
PE(LYR):-10.49

Loading ...

Genscript Highlights Strong CARVYKTI Sales via Legend Biotech, Urges Investor Caution

TIPRANKS
·
Jul 15

Legend Biotech: Carvykti® Generated About $657 Million in Net Trade Sales During Qtr Ended June 30, 2026

THOMSON REUTERS
·
Jul 15

Barclays Sticks to Its Buy Rating for Legend Biotech (LEGN)

TIPRANKS
·
Jul 14

Legend Biotech Price Target Announced at $35.00/share by JP Morgan

Dow Jones
·
Jul 13

Legend Biotech is Maintained at Outperform by RBC Capital

Dow Jones
·
Jul 08

RBC Capital Adjusts Legend Biotech Price Target to $63 From $64, Maintains Outperform Rating

MT Newswires Live
·
Jul 07

Legend Biotech Insider Move: Director Offloads Stake in High-Profile Transaction

TIPRANKS
·
Jul 03

Legend Biotech Director Casey Patrick John Disposes of 6,000 Common Shares for $88,800

Reuters
·
Jul 03

Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.d., to Board of Directors

THOMSON REUTERS
·
Jun 23

Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors

GlobeNewswire
·
Jun 23

Legend Biotech Prices $226 Million ADS Offering to Bolster Cell Therapy Expansion

TIPRANKS
·
Jun 23

Legend Biotech prices 7,700,000 ADS follow-on offering at $29.35 each

Reuters
·
Jun 23

Movement Alert|Legend Biotech Rises 5.44% in Regular Trading, $226 Million ADS Offering Completed Combined with Positive Lymphoma Therapy Data

Market Focus
·
Jun 23

3 US Growth Stocks With Strong Balance Sheets And Earnings Focus

Simply Wall St.
·
Jun 19

Legend Biotech (LEGN) Stock Could Be 51.2% Undervalued After Equity Raise And LB2501 Data

Simply Wall St.
·
Jun 19

Movement Alert|Legend Biotech Falls 16.02% in Regular Trading, Secondary Offering of $226 Million ADS Priced at Discount

Market Focus
·
Jun 19

BUZZ-U.S. STOCKS ON THE MOVE-Kardigan, Energy companies

Reuters
·
Jun 18

Legend Biotech falls -12.2%

TIPRANKS
·
Jun 18

BUZZ-U.S. STOCKS ON THE MOVE-Pfizer, Accenture, Kroger

Reuters
·
Jun 18

Legend Biotech, Sleep Number And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Benzinga_recent_news
·
Jun 18